Discover Novo's pipeline in 2026, as it recently set out a new plan to reach $23 billion in risk-adjusted pipeline sales by ...
Learn when TIDE-based Sanger sequencing can replace NGS for measuring on-target gene editing efficiency in regulated ...
Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer, as Hansoh Pharma and Medilink bring momentum with ...
Three big bets in metabolic disease: the race to challenge Lilly and Novo, a pill that mimics exercise, and a gene therapy ...
Explore the preclinical research catching our eye in October 2026, from AI drug design to small molecules and gene therapy ...
Lab consumables can affect sterility, contamination, reproducibility, and yield. Learn what to consider when selecting your ...
Known for its freezing winters, Finland is warming up to global entrepreuners and investors to boost its life science ...
As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results